Anne-Marie Koop

22 53. Piek A, Boer RA de, Silljé HHW. The fibrosis-cell death axis in heart failure. Heart Fail Rev 2016;21:199–211. 54. Paulin R, Sutendra G, Gurtu V, Dromparis P, Haromy A, Provencher S, Bonnet S, Michelakis ED. A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension. Circ Res 2015;116:56–69. 55. Koshy SKG, Reddy HK, Shukla HH. Collagen cross-linking: New dimension to cardiac remodeling. Cardiovasc Res 2003;57:594–598. 56. Gomez-Arroyo J, Mizuno S, Szczepanek K, Tassell B Van, Natarajan R, Remedios CG Dos, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, Chalfant CE, Bigbee J, Abbate A, Lesnefsky EJ, Bogaard HJ, Voelkel NF. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Hear Fail N.F. Voelkel, Victoria Johnson Center for Lung Obstructive Disease Research, Virginia Commonwealth University, Richmond, VA 23298, United States; 2013;6:136–144. 57. Sutendra G, Dromparis P, Paulin R, Zervopoulos S, Haromy A, Nagendran J, Michelakis ED. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med E.D. Michelakis, Department of Medicine, University of Alberta, Edmonton, AB T6G 2B7, Canada; 2013;91:1315–1327. 58. Nagendran J, Gurtu V, Fu DZ, Dyck JRB, Haromy A, Ross DB, Rebeyka IM, Michelakis ED. A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg E.D. Michelakis, Pulmonary Hypertension Program, Department of Medicine, University of Alberta, Edmonton, Alta., Canada; 2008;136:168-178.e3. 59. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006;114:1883–1891. 60. Nagendran J, Michelakis ED. Mitochondrial NOS is upregulated in the hypoxic heart: implications for the function of the hypertrophied right ventricle. Am J Physiol Heart Circ Physi ol 2009;296:H1723-6. 61. Neubauer S. The Failing Heart — An Engine Out of Fuel. N Engl J Med 2007;356:1140–1151. 62. Ryan JJ, Huston J, Kutty S, Hatton ND, Bowman L, Tian L, Herr JE, Johri AM, Archer SL. Right Ventricular Adaptation and Failure in Pulmonary Arterial Hypertension. Can J Cardiol Canadian Cardiovascular Society; 2015;31:391–406. 63. Ahmadi A, Ohira H, Mielniczuk LM. FDG PET imaging for identifying pulmonary hypertension and right heart failure. Curr Cardiol Rep 2015;17:555. 64. Archer SL, Fang Y-H, Ryan JJ, Piao L. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension. Pulm Circ United States; 2013;3:144–152. 65. Bruns DR, Dale Brown R, Stenmark KR, Buttrick PM, Walker LA. Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunction. Am J Physiol - Lung Cell Mol Physiol L.A. Walker, Univ. of Colorado-Denver, Dept. of Medicine, Cardiology, Aurora, United States; 2015;308:L158–L167.